This article on Epainassist.com has been reviewed by a medical professional, as well as checked for facts, to assure the readers the best possible accuracy.

We follow a strict editorial policy and we have a zero-tolerance policy regarding any level of plagiarism. Our articles are resourced from reputable online pages. This article may contains scientific references. The numbers in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.

The feedback link “Was this Article Helpful” on this page can be used to report content that is not accurate, up-to-date or questionable in any manner.

This article does not provide medical advice.


Peristalsis and Its Impact on Novel Drug Delivery Systems: An In-depth Analysis

The medical and pharmaceutical fields are continually evolving, and novel drug delivery systems (NDDS) represent a significant advancement. These cutting-edge technologies aim to administer medications in a controlled manner, improving efficacy and patient compliance. One fundamental physiological process that impacts these systems is peristalsis. This article explores the role of peristaltic movement in novel drug delivery systems.

Peristalsis: The Basics

Peristalsis refers to the rhythmic, wave-like contractions and relaxations of the muscles in the digestive tract. These involuntary movements propel food and liquid from the esophagus, through the stomach and intestines, and finally to the rectum.

Peristalsis in Drug Delivery

Understanding peristalsis is vital for designing effective drug delivery systems. Here’s why: 

  • Transit Time: Peristaltic movement governs the transit time of a drug delivery system in the gastrointestinal (GI) tract. The quicker the peristalsis, the less time a drug has to be absorbed.
  • Site-Specific Delivery: Certain drugs are most effective when released at specific sites in the GI tract. Peristaltic movement can influence where a drug is released. For instance, slower peristalsis in the colon can be leveraged for targeted drug delivery.

Peristalsis and Novel Drug Delivery Systems

Gastroretentive Drug Delivery Systems (GRDDS)

One area where peristalsis plays a crucial role is in the development of gastroretentive drug delivery systems. These systems are designed to prolong gastric retention time, allowing for extended drug release. This is particularly useful for drugs that are absorbed primarily in the stomach or upper small intestine.

However, rapid peristalsis can pose a challenge to GRDDS, as the system may be transported into the intestine before the drug is fully released. As a result, these systems often incorporate mechanisms to resist the peristaltic movement, such as floating, expanding, or adhering to the gastric mucosa.

Controlled-Release Systems

Controlled-release systems aim to deliver drugs at a predetermined rate for a specific period, thereby maintaining the therapeutic drug concentration in the bloodstream. These systems have to consider the transit times and varying pH levels along the GI tract, which are influenced by peristalsis.

Targeted Drug Delivery

For drugs that are most effective or have fewer side effects when delivered to a specific site in the GI tract, understanding and utilizing peristaltic movement is key. For example, certain anti-inflammatory drugs used for inflammatory bowel disease (IBD) are designed to be released in the colon, where peristalsis is typically slower.


As we move towards more advanced and tailored treatment approaches, understanding the complex interplay of physiological processes becomes increasingly important. Peristalsis, a fundamental digestive mechanism, has a significant role in the design and effectiveness of novel drug delivery systems. By studying this process, researchers can create more targeted, efficient, and patient-friendly drug delivery methods.

Remember, this information is meant to provide a comprehensive understanding and should not be used as a replacement for professional medical consultation. Always consult with a healthcare professional or a pharmacist for concerns or queries about medication.


  • Sharma, N., & Madan, P. (2016). Effect of Peristalsis on Gastroretentive Drug Delivery Systems. Current drug delivery, 13(4), 497–511. https://doi.org/10.2174/1567201813666150821114017
  • Chandel, A., Chauhan, K., Parashar, B., Kumar, H., & Arora, S. (2011). Gastroretentive Drug Delivery Systems: A Review. International Journal of Pharmacy and Pharmaceutical Sciences, 3(Suppl 2), 2-7.
  • Maroni, A., Zema, L., Del Curto, M. D., & Loreti, G. (2010). Oral pulsatile delivery: Rationale and chronopharmaceutical formulations. International Journal of Pharmaceutics, 398(1-2), 1–8. https://doi.org/10.1016/j.ijpharm.2010.07.024

Also Read:

Team PainAssist
Team PainAssist
Written, Edited or Reviewed By: Team PainAssist, Pain Assist Inc. This article does not provide medical advice. See disclaimer
Last Modified On:August 5, 2023

Recent Posts

Related Posts